tb500 peptide and bpc-157 & TB-500 Blend Research Peptides | >99% Purity BPC-157 / TB-500 Mix |

**Quick calculator (30mg vial at 10mg/ml):** | Weekly Dose | Volume per Injection | Syringe Units | Doses per Vial | |------------|---------------------|---------------|----------------| | 1mg | 0.10ml | 10 units | 30 doses | | 2mg | 0.20ml | 20 units | 15 doses | | 4mg | 0.40ml | 40 units | 7.5 doses | | 8mg | 0.80ml | 80 units | 3.75 doses | | 12mg | 1.20ml | Split: 60 units x2 | 2.5 doses | ## Universal Mixing Calculator Use this formula for any vial size and desired concentration: **BAC Water (ml) = Vial Size (mg) Desired Concentration (mg/ml)** **Injection Volume (ml) = Desired Dose (mg) Concentration (mg/ml)** **Syringe Units = Injection Volume (ml) 100** ### Example Calculation You have a 50mg vial and want 10mg/ml concentration: - BAC water: 50mg 10mg/ml = 5.0ml - For a 4mg dose: 4mg 10mg/ml = 0.4ml = 40 units - For an 8mg dose: 8mg 10mg/ml = 0.8ml = 80 units ## Which Vial Size Should You Choose

Payment for Skin Substitutes Under the Outpatient Prospective Payment System (OPPS) Prior to CY 2014, all products considered to be skin substitutes were separately paid under the OPPS as if they were biologicals according to the ASP methodology (78 FR 74930 through 74931)

As set forth in Table C-G3 in section IV.A.4.d.(4).(h).(i)

we offer a comprehensive program designed to address the specific needs of overweight and obese patients

Adopting a similar performance threshold and payment adjustment approach for ASM would introduce several operational complexities

Most early non-responders are not failing, they are not waiting long enough